Bausch Health Companies Inc. (TSE:BHC – Get Free Report) shares traded down 1.5% during trading on Wednesday . The company traded as low as C$10.25 and last traded at C$10.27. 34,054 shares were traded during mid-day trading, a decline of 90% from the average session volume of 352,127 shares. The stock had previously closed at C$10.43.
Wall Street Analysts Forecast Growth
Separately, Raymond James raised Bausch Health Companies to a “hold” rating in a research report on Wednesday, July 10th.
Bausch Health Companies Stock Down 24.6 %
Bausch Health Companies (TSE:BHC – Get Free Report) last issued its quarterly earnings results on Thursday, May 2nd. The company reported C$0.80 earnings per share for the quarter, missing analysts’ consensus estimates of C$1.02 by C($0.22). Bausch Health Companies had a negative net margin of 5.07% and a negative return on equity of 686.52%. The business had revenue of C$2.90 billion for the quarter, compared to analysts’ expectations of C$2.98 billion. As a group, equities analysts anticipate that Bausch Health Companies Inc. will post 4.85 earnings per share for the current fiscal year.
About Bausch Health Companies
Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.
Read More
- Five stocks we like better than Bausch Health Companies
- Why Invest in 5G? How to Invest in 5G Stocks
- Food Processing Company Stock Gets Fried by Recall: Time to Buy
- Which Wall Street Analysts are the Most Accurate?
- Entertainment Stock Offers A Rare and Tempting Entry Opportunity
- What Are Trending Stocks? Trending Stocks Explained
- Will China’s Interest Rate Cuts Ignite a Rally for This Stock?
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.